Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
FLGT

FLGT - Fulgent Genetics Inc Stock Price, Fair Value and News

$26.41-0.86 (-3.15%)
Market Closed

60/100

FLGT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

60/100

FLGT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$33.47

Target 3M

$29.13

Target 6M

$30.52

FLGT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FLGT Price Action

Last 7 days

-5.2%

Last 30 days

-0.7%

Last 90 days

17.0%

Trailing 12 Months

53.7%

FLGT RSI Chart

FLGT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FLGT Valuation

Market Cap

816.4M

Price/Earnings (Trailing)

-18.87

Price/Sales (Trailing)

2.59

EV/EBITDA

-28.53

Price/Free Cashflow

-41.13

FLGT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$33.47

Target 3M

$29.13

Target 6M

$30.52

FLGT Fundamentals

FLGT Revenue

Revenue (TTM)

315.5M

Rev. Growth (Yr)

17.18%

Rev. Growth (Qtr)

2.77%

FLGT Earnings

Earnings (TTM)

-43.3M

Earnings Growth (Yr)

54.89%

Earnings Growth (Qtr)

65.68%

FLGT Profitability

Operating Margin

41.24%

EBT Margin

-15.46%

Return on Equity

-3.84%

Return on Assets

-3.56%

Free Cashflow Yield

-2.43%

FLGT Investor Care

Shares Dilution (1Y)

1.06%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025292.4M303.2M315.5M0
2024287.5M290.7M277.8M283.5M
2023364.9M307.4M286.4M289.2M
2022953.4M925.1M802.9M619.0M
2021773.4M909.7M1.0B992.6M
202034.9M43.8M135.1M421.7M
201922.1M25.1M29.8M32.5M
201818.1M18.8M20.0M21.4M
201720.1M20.8M20.3M18.7M
201611.4M13.2M15.3M18.3M
20153.4M5.4M7.5M9.6M
20140001.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Fulgent Genetics Inc

FLGT
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and next generation sequencer services related to hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics, as well as pharmacogenetic tests. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to enhance the therapeutic window and pharmacokinetic profile, or PK profile, of new and existing cancer drugs. The company also operates picture genetics platform which includes proprietary gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
 CEO
 WEBSITEfulgentgenetics.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES1012

Fulgent Genetics Inc Frequently Asked Questions

FLGT is the stock ticker symbol of Fulgent Genetics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Fulgent Genetics Inc is 816.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check FLGT's fair value in chart for subscribers.

The fair value guage provides a quick view whether FLGT is over valued or under valued. Whether Fulgent Genetics Inc is cheap or expensive depends on the assumptions which impact Fulgent Genetics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FLGT.

As of Wed Jan 28 2026, FLGT's PE ratio (Price to Earnings) is -18.87 and Price to Sales (PS) ratio is 2.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FLGT PE ratio will change depending on the future growth rate expectations of investors.